Cardiovascular disease in polycystic ovary syndrome

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 823-824

  Atkin, S L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERANDROGENISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LONG TERM CARE; MENSTRUAL IRREGULARITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME;

EID: 84876539627     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12151     Document Type: Note

References (12)

1. Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., et al,. (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism, 95, 2038-2049.
2. Sathyapalan, T., &, Atkin, S.L., (2012) Recent advances in cardiovascular aspects of polycystic ovary syndrome. European Journal of Endocrinology, 166, 575-583.
3. Randeva, H.S., Tan, B.K., Weickert, M.O., et al,. (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews, 33, 812-841.
4. Solomon, C.G., Hu, F.B., Dunaif, A., et al,. (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 87, 2013-2017.
5. Wang, E.T., Cirillo, P.M., Vittinghoff, E., et al,. (2011) Menstrual irregularity and cardiovascular mortality. Journal of Clinical Endocrinology and Metabolism, 96, E114-E118.
6. Laughlin, G.A., Goodell, V., &, Barrett-Connor, E., (2009) Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. Journal of Clinical Endocrinology and Metabolism, 95, 740-747.
7. Patel, S.M., Ratcliffe, S.J., Reilly, M.P., et al,. (2009) Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 94, 4776-4784.
8. Puurunen, J., Piltonen, T., Morin-Papunen, L., et al,. (2011) Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. Journal of Clinical Endocrinology and Metabolism, 96, 1827-1834.
9. Mani, H., Levy, M.J., Davies, M.J., et al,. (2012) Diabetes and cardiovascular events in women with polycystic ovary syndrome; a 20 years retrospective cohort study. Clinical Endocrinology (Oxford), 78, 926-934.
10. Laughlin, G.A., Goodell, V., &, Barrett-Connor, E., (2010) Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. Journal of Clinical Endocrinology and Metabolism, 95, 740-747.
11. Morgan, C.L., Jenkins-Jones, S., Currie, C.J., et al,. (2012) Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. Journal of Clinical Endocrinology and Metabolism, 97, 3251-3260.
12. Moran, L.J., Misso, M.L., Wild, R.A., et al,. (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 16, 347-363.